Pell Bio-Med Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	306.7	427.37	167.68	172.4	115.78
Short-Term Investments	351	479.75	938.15	536	-
Trading Asset Securities	-	29.06	-	-	-
Cash & Short-Term Investments	657.7	936.18	1,106	708.4	115.78
Cash Growth	-29.75%	-15.34%	56.10%	511.84%	-
Accounts Receivable	5.07	3.75	7.61	6.05	4.5
Other Receivables	3.21	2.4	0.33	0.36	6.12
Receivables	8.27	6.15	7.94	6.41	10.62
Inventory	6.62	6.18	3.76	4.58	4.24
Prepaid Expenses	5.46	9.22	8.86	5.84	1.1
Other Current Assets	653.37	200	0.65	0.16	0.08
Total Current Assets	1,331	1,158	1,127	725.39	131.82
Property, Plant & Equipment	709.81	386.45	260.92	298.97	249.74
Long-Term Investments	0.27	0.37	0.37	0.26	0.26
Other Intangible Assets	2.93	1.89	2.4	2.71	1.47
Other Long-Term Assets	67.8	198.39	27.44	17.07	10.61
Total Assets	2,112	1,745	1,418	1,044	393.89
Accounts Payable	5.83	4.49	6.99	5.72	8.61
Accrued Expenses	106.49	64.12	39.74	14.58	19.19
Short-Term Debt	100	200	-	5	-
Current Portion of Leases	27.99	27.55	25.09	25.07	10.76
Current Unearned Revenue	0.02	0.02	-	-	0.75
Other Current Liabilities	68.64	25.17	17.47	6.86	4.87
Total Current Liabilities	308.97	321.35	89.3	57.24	44.18
Long-Term Leases	109.28	137.27	147.47	172.56	124.84
Other Long-Term Liabilities	0.02	-	-	-	-
Total Liabilities	418.27	458.62	236.77	229.79	169.02
Common Stock	587.98	578.43	539.43	443.65	333.76
Additional Paid-In Capital	1,910	1,804	1,449	774.25	77.38
Retained Earnings	-1,631	-1,207	-817.85	-419.09	-188.96
Treasury Stock	-0.8	-0.8	-0.8	-	-
Comprehensive Income & Other	555.74	5.52	-	2.13	2.69
Total Common Equity	1,422	1,180	1,170	800.94	224.86
Minority Interest	272.07	106.29	11.18	13.67	0.01
Shareholders' Equity	1,694	1,286	1,181	814.6	224.87
Total Liabilities & Equity	2,112	1,745	1,418	1,044	393.89
Total Debt	237.27	364.82	172.56	202.63	135.6
Net Cash (Debt)	420.43	571.36	933.27	505.77	-19.82
Net Cash Growth	-26.41%	-38.78%	84.52%	-	-
Net Cash Per Share	7.17	10.01	20.17	12.89	-0.60
Filing Date Shares Outstanding	58.72	57.8	53.9	44.36	33.28
Total Common Shares Outstanding	58.72	57.8	53.9	44.36	33.28
Working Capital	1,022	836.38	1,038	668.15	87.64
Book Value Per Share	24.22	20.41	21.71	18.05	6.76
Tangible Book Value	1,419	1,178	1,168	798.22	223.39
Tangible Book Value Per Share	24.17	20.38	21.67	17.99	6.71
Machinery	310.33	95.05	90.37	81.84	75.31
Construction In Progress	285.99	148.34	-	-	-
Leasehold Improvements	104.12	86.72	86.72	86.18	86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.